Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Catabasis Pharmaceuticals
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Between 18 and 74 years at Screening
Hypercholesterolemia (LDL-C ≥ 70 mg/dL and \< 190 mg/dL) plus a stable dose of statin for at least 4 weeks prior to Screening
Satisfies one of the following:
1. Female patients of childbearing potential must have used appropriate and highly effective contraception (a regimen which results in a failure rate of \<1% per year) with their partners for 4 weeks prior to Screening, and remain compliant during the treatment phase and until 4 weeks after the last dose of investigational product
2. Male patients must use an acceptable and highly effective contraceptive method during the treatment phase and until 4 weeks after the last dose of investigational product
Body mass index (BMI) ≤45 kg/m2
You may not be if
History of any major cardiovascular event (stroke, TIA, MI, PTCI, CABG, hospitalization due to heart failure) within 6 months of Screening
Type I diabetes mellitus or use of insulin
Active peptic ulcer disease or a history of muscle disease or myopathy
